Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
Talarico GP, Brancati M, Burzotta F, Porto I, Trani C, De Vita M, Todaro D, Giammarinaro M, Leone AM, Niccoli G, Andreotti F, Mazzari MA, Schiavoni G, Crea F. Talarico GP, et al. Among authors: todaro d. J Cardiovasc Med (Hagerstown). 2009 Mar;10(3):245-51. doi: 10.2459/JCM.0b013e32832180d9. J Cardiovasc Med (Hagerstown). 2009. PMID: 19262211 Clinical Trial.
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents.
Burzotta F, Trani C, Todaro D, Lanza GA, Mariani L, Tommasino A, Niccoli G, Porto I, Leone AM, Crea F. Burzotta F, et al. Among authors: todaro d. Catheter Cardiovasc Interv. 2012 Feb 15;79(3):351-9. doi: 10.1002/ccd.23218. Epub 2011 Dec 12. Catheter Cardiovasc Interv. 2012. PMID: 21735527 Clinical Trial.
Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.
Sgueglia GA, Burzotta F, Trani C, Todaro D, Talarico GP, Niccoli G, Porto I, Leone AM, Coluccia V, Mazzari MA, Mongiardo R, Schiavoni G, Crea F. Sgueglia GA, et al. Among authors: todaro d. Catheter Cardiovasc Interv. 2011 Mar 1;77(4):503-9. doi: 10.1002/ccd.22714. Catheter Cardiovasc Interv. 2011. PMID: 20602477
Comparison of the transradial and transfemoral approaches for coronary angiographic evaluation in patients with internal mammary artery grafts.
Burzotta F, Trani C, Todaro D, Romagnoli E, Niccoli G, Ginnico F, Talarico GP, Tommasino A, Mazzari MA, Mongiardo R, Schiavoni G, Crea F. Burzotta F, et al. Among authors: todaro d. J Cardiovasc Med (Hagerstown). 2008 Mar;9(3):263-6. doi: 10.2459/JCM.0b013e32801da15a. J Cardiovasc Med (Hagerstown). 2008. PMID: 18301143
Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry.
Burzotta F, Trani C, Todaro D, Mazzari MA, Porto I, De Vita M, Brugaletta S, Coroleu SF, Niccoli G, Leone AM, Giammarinaro M, Mongiardo R, Schiavoni G, Crea F. Burzotta F, et al. Among authors: todaro d. Catheter Cardiovasc Interv. 2009 Mar 1;73(4):457-65. doi: 10.1002/ccd.21882. Catheter Cardiovasc Interv. 2009. PMID: 19229977
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.
Burzotta F, Trani C, Todaro D, Mariani L, Talarico GP, Tommasino A, Giammarinaro M, Niccoli G, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F. Burzotta F, et al. Among authors: todaro d. JACC Cardiovasc Interv. 2011 Mar;4(3):327-35. doi: 10.1016/j.jcin.2010.12.005. JACC Cardiovasc Interv. 2011. PMID: 21435612 Free article. Clinical Trial.
66 results